Allarity Therapeutics (ALLR)
0.75
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K Allarity Therapeutics, For: Sep 22
September 27, 2023 4:30 PM - SEC Filing
Form D Allarity Therapeutics,
September 21, 2023 6:02 AM - SEC Filing
Form 8-K Allarity Therapeutics, For: Sep 14
September 15, 2023 8:45 AM - SEC Filing
Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering F
September 14, 2023 9:28 AM - StreetInsider
Allarity Therapeutics (ALLR) Reports Publication on DRP Companion Diagnostic for Dovitinib
August 30, 2023 4:07 PM - StreetInsider
PLOS ONE Publishes Data on Allarity Therapeutics’ DRP® Companion Diagnostic for Dovitinib
August 30, 2023 4:05 PM - StreetInsider
Form 3 Allarity Therapeutics, For: Aug 01 Filed by: Benjamin Laura
August 28, 2023 5:03 PM - SEC Filing
Form 10-Q Allarity Therapeutics, For: Jun 30
August 14, 2023 3:11 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Aug 07
August 11, 2023 8:15 AM - SEC Filing
Form 3 Allarity Therapeutics, For: Aug 01 Filed by: Vazzano Joseph Walter
August 2, 2023 9:20 PM - SEC Filing
Allarity Therapeutics (ALLR) and FivepHusion Partner to Support Clinical Development of Deflexifol with DRP
July 31, 2023 6:03 AM - StreetInsider
Allarity Therapeutics and FivepHusion Announce Collaboration to Support Clinical Development of Deflexifol™ with DRP® Companion Diagnostics
July 31, 2023 6:00 AM - StreetInsider
Form 8-K Allarity Therapeutics, For: Jul 21
July 27, 2023 4:02 PM - SEC Filing
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
July 24, 2023 6:00 AM - StreetInsider
Form 8-K Allarity Therapeutics, For: Jul 14
July 17, 2023 5:11 PM - SEC Filing
Form SC 13G Allarity Therapeutics, Filed by: INTRACOASTAL CAPITAL, LLC
July 14, 2023 5:27 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Jul 05
July 11, 2023 4:05 PM - SEC Filing
Form 424B4 Allarity Therapeutics,
July 7, 2023 4:31 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Jul 05
July 6, 2023 6:06 AM - SEC Filing
Form EFFECT Allarity Therapeutics,
July 6, 2023 6:03 AM - SEC Filing
Allarity Therapeutics (ALLR) Prices 2.44M Share Offering at $4.50/sh
July 6, 2023 6:00 AM - StreetInsider
Allarity Therapeutics, Inc. Announces Pricing of $11 Million Public Offering
July 6, 2023 6:00 AM - StreetInsider
Form 8-K Allarity Therapeutics, For: Jul 05
July 5, 2023 4:31 PM - SEC Filing
Allarity Therapeutics (ALLR) Reports Initial Data from Phase 2 Trial of IXEMPRA Indicate Potential for Improved Clinical Benefit in DRP-Selected Metastatic Breast Cancer Patients
July 5, 2023 9:46 AM - StreetInsider
Initial Data from Allarity’s Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients
July 5, 2023 9:45 AM - StreetInsider
Form S-1/A Allarity Therapeutics,
June 30, 2023 5:24 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Jun 29
June 30, 2023 4:06 PM - SEC Filing
Full Article List
